Literature DB >> 32540304

OSA in Professional Transport Operations: Safety, Regulatory, and Economic Impact.

Indira Gurubhagavatula1, Miranda Tan2, Aesha M Jobanputra3.   

Abstract

OSA is common among commercial vehicle operators (CVOs) in all modes of transportation, including truck, bus, air, rail, and maritime operations. OSA is highly prevalent and increases the risk of drowsiness-related crashes in CVOs. Internationally, specific regulations regarding its identification and management vary widely or do not exist; medical examiners and sleep medicine specialists are urged to use available guidance documents in their absence. Education, screening, prompt identification and treatment, and ongoing surveillance to ensure effective therapy can lower the risk of fatigue-related crashes.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CPAP; OSA; commercial vehicle operators; drowsy driving; sleep apnea; sleep medicine; sleep-disordered breathing

Mesh:

Year:  2020        PMID: 32540304     DOI: 10.1016/j.chest.2020.05.582

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Epidemiology, Physiology and Clinical Approach to Sleepiness at the Wheel in OSA Patients: A Narrative Review.

Authors:  Maria R Bonsignore; Carolina Lombardi; Simone Lombardo; Francesco Fanfulla
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Poor performance of screening questionnaires for obstructive sleep apnea in male commercial drivers.

Authors:  Alessandro Adami; Davide Tonon; Antonio Corica; Deborah Trevisan; Giovanni Cipriano; Nicoletta De Santis; Massimo Guerriero; Gianluca Rossato
Journal:  Sleep Breath       Date:  2021-06-16       Impact factor: 2.816

3.  Global Risk Factor Evaluation of Obstructive Sleep Apnea in Relation to Research Activity and Socioeconomic Factors.

Authors:  Rebekka K Seeger-Zybok; Doris Klingelhöfer; David A Groneberg
Journal:  Int J Environ Res Public Health       Date:  2020-09-17       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.